Astex Therapeutics
Trending Articles
Related Content
Ingredients
Therapeutic: capivasertib as an anticancer agent
Although endocrine therapies are a cornerstone of many treatments for hormone-dependent cancers, resistance to first-line CDK4/6 inhibitors and endocrine therapies often develop. This leaves only limited treatment options and, as a result, alternatives are much needed
Research & Development
Astex enters into agreement with Merck to identify small molecule candidates
Astex Pharmaceuticals has entered into an exclusive research collaboration with Merck to identify small molecule candidates with activity towards a tumour suppressor protein for the treatment of cancer